GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (UKEX:PFE) » Definitions » Cyclically Adjusted Book per Share

Pfizer (UKEX:PFE) Cyclically Adjusted Book per Share : ₴540.80 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pfizer Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pfizer's adjusted book value per share for the three months ended in Mar. 2024 was ₴652.850. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₴540.80 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Pfizer's average Cyclically Adjusted Book Growth Rate was 4.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pfizer was 27.40% per year. The lowest was 0.90% per year. And the median was 8.00% per year.

As of today (2024-05-26), Pfizer's current stock price is ₴1014.00. Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₴540.80. Pfizer's Cyclically Adjusted PB Ratio of today is 1.88.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.72. And the median was 2.87.


Pfizer Cyclically Adjusted Book per Share Historical Data

The historical data trend for Pfizer's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Cyclically Adjusted Book per Share Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 551.63

Pfizer Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 551.63 540.80

Competitive Comparison of Pfizer's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PB Ratio falls into.



Pfizer Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=652.85/131.7762*131.7762
=652.850

Current CPI (Mar. 2024) = 131.7762.

Pfizer Quarterly Data

Book Value per Share CPI Adj_Book
201406 484.330 100.560 634.681
201409 496.048 100.428 650.889
201412 454.201 99.070 604.149
201503 438.019 99.621 579.400
201506 434.666 100.684 568.896
201509 433.911 100.392 569.562
201512 420.026 99.792 554.646
201603 408.185 100.470 535.372
201606 414.710 101.688 537.417
201609 418.073 101.861 540.855
201612 393.119 101.863 508.564
201703 393.242 102.862 503.780
201706 393.305 103.349 501.487
201709 408.586 104.136 517.037
201712 478.004 104.011 605.604
201803 472.872 105.290 591.828
201806 477.078 106.317 591.323
201809 494.504 106.507 611.829
201812 444.517 105.998 552.622
201903 424.121 107.251 521.108
201906 429.240 108.070 523.400
201909 471.766 108.329 573.875
201912 457.318 108.420 555.834
202003 469.433 108.902 568.037
202006 464.406 108.767 562.648
202009 470.814 109.815 564.970
202012 455.414 109.897 546.083
202103 491.788 111.754 579.896
202106 501.531 114.631 576.542
202109 540.821 115.734 615.784
202112 550.726 117.630 616.959
202203 591.035 121.301 642.075
202206 625.116 125.017 658.915
202209 661.741 125.227 696.352
202212 682.900 125.222 718.645
202303 717.127 127.348 742.064
202306 703.241 128.729 719.889
202309 688.311 129.860 698.470
202312 632.072 129.419 643.582
202403 652.850 131.776 652.850

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Pfizer  (UKEX:PFE) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pfizer's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1014.00/540.8
=1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.72. And the median was 2.87.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pfizer Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Pfizer's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (UKEX:PFE) Business Description

Industry
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (UKEX:PFE) Headlines